MétaCan
Menu
Back to cohort

Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome

2022· review· en· W4226021965 on OpenAlexaff
Raphaèle Séror, Gabriel Baron, Marine Camus, Divi Cornec, Élodie Perrodeau, Simon Bowman, Hendrika Bootsma, Jacques‐Eric Gottenberg, Benjamin A. Fisher, Wolfgang Hueber, J.A. van Roon, Valérie Devauchelle‐Pensec, P Gergely, Xavier Mariette, Raphaël Porcher

Bibliographic record

VenueAnnals of the Rheumatic Diseases · 2022
Typereview
Languageen
FieldMedicine
TopicSalivary Gland Disorders and Functions
Canadian institutionsHotel Dieu Hospital
FundersMedical Research CouncilNovartis PharmaServierNational Institute for Health and Care ResearchInnovative Medicines InitiativeSjögren's FoundationBirmingham Biomedical Research CentreBristol-Myers SquibbEli Lilly and CompanyAstraZenecaCSL BehringGilead SciencesUnion Chimique BelgeEuropean Federation of Pharmaceutical Industries and AssociationsEuropean CommissionSanofiGlaxoSmithKlineAmgenPfizer
KeywordsMedicineDelphi methodClinical endpointDelphiPatient-reported outcomeClinical trialRandomized controlled trialPhysical therapyInternal medicineQuality of life (healthcare)Computer scienceArtificial intelligence

Abstract

fetched live from OpenAlex

OBJECTIVE: To develop a composite responder index in primary Sjögren's syndrome (pSS): the Sjögren's Tool for Assessing Response (STAR). METHODS: To develop STAR, the NECESSITY (New clinical endpoints in primary Sjögren's syndrome: an interventional trial based on stratifying patients) consortium used data-driven methods based on nine randomised controlled trials (RCTs) and consensus techniques involving 78 experts and 20 patients. Based on reanalysis of rituximab trials and the literature, the Delphi panel identified a core set of domains with their respective outcome measures. STAR options combining these domains were proposed to the panel for selection and improvement. For each STAR option, sensitivity to change was estimated by the C-index in nine RCTs. Delphi rounds were run for selecting STAR. For the options remaining before the final vote, a meta-analysis of the RCTs was performed. RESULTS: The Delphi panel identified five core domains (systemic activity, patient symptoms, lachrymal gland function, salivary gland function and biological parameters), and 227 STAR options combining these domains were selected to be tested for sensitivity to change. After two Delphi rounds, a meta-analysis of the 20 remaining options was performed. The candidate STAR was then selected by a final vote based on metrological properties and clinical relevance. CONCLUSION: The candidate STAR is a composite responder index that includes all main disease features in a single tool and is designed for use as a primary endpoint in pSS RCTs. The rigorous and consensual development process ensures its face and content validity. The candidate STAR showed good sensitivity to change and will be prospectively validated by the NECESSITY consortium in a dedicated RCT.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.161
metaresearch head score (Gemma)0.178
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Theoretical or conceptual · Consensus signal: none
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.161
Threshold uncertainty score0.850

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1610.178
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.005
Bibliometrics0.0040.002
Science and technology studies0.0010.001
Scholarly communication0.0020.002
Open science0.0020.003
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0030.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.107
GPT teacher head0.375
Teacher spread0.268 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designTheoretical or conceptual
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations93
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueAnnals of the Rheumatic DiseasesSame topicSalivary Gland Disorders and FunctionsFrench-language works237,207